Description
Reamberin (meglumine sodium succinate) Solution for Infusion 200 ml. Vial
Reamberin is a medication used for intravenous administration, supplied in a 200 ml. vial. It contains the active ingredients meglumine sodium succinate, which work together to provide therapeutic benefits. This solution is intended for infusion into the bloodstream under medical supervision.
Indications
Reamberin is prescribed for the treatment of various conditions where the correction of metabolic disorders is necessary. The main indications for the use of Reamberin include:
- Acute intoxications
- Metabolic acidosis
- Shock states
- Tissue hypoxia
- Recovery period after severe conditions
Active Ingredients
Reamberin contains the following active ingredients:
- Meglumine
- Sodium succinate
Mechanism of Action
The active ingredients in Reamberin work synergistically to provide the following therapeutic effects:
- Correction of metabolic acidosis
- Stabilization of cell membranes
- Protection against oxidative stress
- Improvement of tissue perfusion
Administration
Reamberin is administered intravenously under medical supervision. The dosage and duration of treatment are determined by the healthcare provider based on the patient’s condition and response to therapy. It is important to follow the recommended dosing schedule to achieve optimal therapeutic outcomes.
Adverse Reactions
Like all medications, Reamberin may cause side effects in some patients. Common adverse reactions associated with Reamberin include:
- Nausea
- Vomiting
- Headache
- Dizziness
- Flushing
If any of these side effects persist or worsen, it is important to notify your healthcare provider immediately. In some cases, serious allergic reactions or adverse events may occur, requiring prompt medical attention.
Precautions
Before using Reamberin, inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking. It is important to follow all instructions provided by your healthcare provider to minimize the risk of adverse reactions.
Reamberin should be used with caution in patients with renal impairment, electrolyte imbalances, or other underlying health conditions. Close monitoring of vital signs and laboratory parameters may be necessary during treatment with Reamberin.
Storage
Store Reamberin Solution for Infusion in its original packaging at room temperature, away from moisture and direct sunlight. Do not freeze the medication. Keep it out of reach of children and pets. Do not use Reamberin beyond the expiration date printed on the packaging.
Conclusion
Reamberin is a medication used for the treatment of metabolic disorders, shock states, and tissue hypoxia. It contains meglumine sodium succinate as active ingredients that work together to provide therapeutic benefits. Before using Reamberin, consult with your healthcare provider to determine the appropriate dosage and administration schedule based on your individual needs. Follow all instructions provided by your healthcare provider to ensure safe and effective treatment with Reamberin.
